April 29, 2022
by Andrii Buvailo
Biopharma insight
If you are a biologist or a drug hunter and you haven’t read a blog by Dr. Vijay Pande, a …
April 26, 2022
by Andrii Buvailo
Interview
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. …
April 25, 2022
by Andrii Buvailo
Biopharma insight
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
April 7, 2022
by Irina Bilous, Andrii Buvailo
Biopharma insight
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Feb. 21, 2022
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
Feb. 8, 2022
by Andrii Buvailo
Biopharma insight
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
Jan. 21, 2022
by Andrii Buvailo
Biopharma insight
In November 2021, the parent company of Google, Alphabet, Inc., announced the launch of a new commercial subsidiary in the …
Oct. 19, 2021
by Andrii Buvailo
Biopharma insight
A Hong Kong-based artificial intelligence (AI)-driven drug discovery company Insilico Medicine has just announced the appointment of Dr. Michelle Chen …
Sept. 24, 2021
by Illia Petrov, Darina Abdulina
Biopharma insight
Over 2020-2021 we have seen a remarkable parade of artificial intelligence (AI), focused on discovering novel therapeutics, going public. This …
Aug. 25, 2021
by Liana Relina, Ilia Petrov
Biopharma insight
Gene therapy is still an investigational technique. Viruses are commonly used as vectors to deliver a needed gene to a …
Aug. 9, 2021
by Andrii Buvailo
Biopharma insight
Table of Contents: Introduction Artificial intelligence (AI) in drug discovery yields breakthroughs The abundance of venture capital, major funding …
July 28, 2021
by Liana Relina, Illia Petrov
Biopharma insight
Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA that are …
July 13, 2021
by Liana Relina, Illia Petrov
Biopharma insight
Common vaccines are synonymous with injections and grant you systemic immunity. But the injection isn’t the only way to develop …
July 10, 2021
by Alex Brown
Biopharma insight
The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging …
July 7, 2021
by Andrii Buvailo, Alexander Korolyov
Biopharma insight
RNA therapeutics at a glance For many years the focus of therapeutic developments and scientific research was directed at the …
May 24, 2021
by Irina Bilous
Biopharma insight
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even …
April 15, 2021
by Aruna Rajan
Biopharma insight
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …
Feb. 11, 2021
by Andrii Buvailo
Biopharma insight
A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to …
July 8, 2020
by Andrii Buvailo
Biopharma insight
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- …
May 12, 2020
by Andrii Buvailo
Interview
Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …